» Authors » Omar-Javier Calixto

Omar-Javier Calixto

Explore the profile of Omar-Javier Calixto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 128
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Arzuaga-Hernandez A, Calixto O, Gomez O, Avila J, Sucerquia-Quintero J, Bello-Gualtero J, et al.
BMC Rheumatol . 2025 Mar; 9(1):28. PMID: 40050979
Introduction: Spondyloarthritis (SpA) exhibits predominantly musculoskeletal symptoms but also significant gastrointestinal (GI) and psychological manifestations. Subclinical gut inflammation is common in SpA, with frequent symptoms such as abdominal pain and...
2.
Calixto O, Kiltz U, Bautista-Molano W, Boonen A, van Kuijk S, Essers I, et al.
Rheumatology (Oxford) . 2025 Jan; PMID: 39878952
Objectives: To compare the utility values of Spondyloarthritis (SpA)-specific ASAS Health Index (U-ASAS-HI) to generic utilities and to understand the contribution of health outcomes, personal- and country-level factors to the...
3.
Calixto O, Meneses-Toro M, Chacon P, Acevedo-Godoy M, Robayo L, Bello-Gualtero J, et al.
Biomedica . 2025 Jan; 44(Sp. 2):178-190. PMID: 39836838
Introduction: Psoriatic arthritis is a complex disease, and human leukocyte antigens (HLA) are key to its development. Latin America and, specifically, Colombia, has scarce data about patients with psoriatic arthritis....
4.
Carvajal-Gutierrez W, Cisneros-Cisneros M, Calixto O, Meneses-Toro M, Rueda A, Vega-Baez M, et al.
Curr Rheumatol Rev . 2024 Feb; 20(5):555-562. PMID: 38362696
Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease. It has been identified that non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids can be essential risk factors for developing complications such as...
5.
Calixto O, Meneses-Toro M, Vera-Parra E, Bello-Gualtero J, Romero-Sanchez C, Perdomo S
Autoimmun Rev . 2023 Jul; 22(9):103393. PMID: 37487969
Background And Aims: Psoriatic arthritis (PsA) is an inflammatory complex condition. Posttranslational modifications influence almost all aspects of normal cell biology and pathogenesis. The aim of this systematic review was...
6.
Calixto O, Poveda S, Meneses-Toro M, Vera-Parra E, Romero-Sanchez C, Guzman Molano L, et al.
Lupus . 2023 Jun; 32(9):1123-1125. PMID: 37369195
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an uncommon subtype of peripheral neuropathy, especially in systemic lupus erythematosus (SLE). We report a case of SLE presenting with CIDP successfully treated. The...
7.
Santos-Moreno P, Sanchez-Vanegas G, Monterrosa-Blanco A, Rodriguez-Vargas G, Rivero M, Rodriguez P, et al.
Biologics . 2022 Nov; 16:199-209. PMID: 36440060
Purpose: To assess, in a cohort of patients with rheumatoid arthritis (RA) treated with subcutaneous antitumor necrosis factor drugs (anti-TNFs), the levels of treatment adherence before and after implementing a...
8.
Romero-Sanchez C, Calixto O, Romero-Alvarez V, Vargas-Martin A, Castro L, Amador J, et al.
Diagnostics (Basel) . 2022 Sep; 12(9). PMID: 36140581
Background: The presence of Antinuclear antibodies/Dense Fine Speckled 70 (ANA/DFS70) has been proposed as a negative biomarker in the process of exclusion of systemic autoimmune/autoinflammatory rheumatic diseases (SARD). The purpose...
9.
Magali Chamorro-Melo Y, Calixto O, Bello-Gualtero J, Bautista-Molano W, Beltran-Ostos A, Romero-Sanchez C
Reumatologia . 2022 Jul; 60(3):192-199. PMID: 35875721
Introduction: Adipokines may play a role in the early stages of rheumatoid arthritis. This study evaluated the performance of adipokines in a Colombian population with early rheumatoid arthritis and its...
10.
Silva-Ramos C, Faccini-Martinez A, Calixto O, Hidalgo M
Travel Med Infect Dis . 2021 Feb; 40:102001. PMID: 33640478
Bolivian hemorrhagic fever (BHF) is a sporadic high-mortality febrile illness. Two etiological agents are currently recognized: Machupo virus and Chapare virus. Infection in humans occurs by exposure to excreta and...